Moderna（MRNA）今日盘中大涨5.05%，表现亮眼。
消息面上，Moderna在摩根大通医疗保健大会上表示，预计2025年营收约为19亿美元，高于此前预期的中值。此外，公司重申2026年营收增长目标为最高10%，并预计年内将获得两款疫苗的监管批准，包括独立流感疫苗和新冠-流感联合疫苗。这些积极信号提振了市场对该公司后疫情时代业务稳定性的信心。
Moderna（MRNA）今日盘中大涨5.05%，表现亮眼。
消息面上，Moderna在摩根大通医疗保健大会上表示，预计2025年营收约为19亿美元，高于此前预期的中值。此外，公司重申2026年营收增长目标为最高10%，并预计年内将获得两款疫苗的监管批准，包括独立流感疫苗和新冠-流感联合疫苗。这些积极信号提振了市场对该公司后疫情时代业务稳定性的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.